Background A strong link between disease severity and Staphylococcus aureus colonization of the skin has been reported in patients with atopic dermatitis (AD). Objectives To examine temporal variations in S. aureus colonization and S. aureus CC type in patients with AD, and to investigate links to disease severity, skin barrier properties and filaggrin gene (FLG) mutations. Methods This was a follow-up study of a cohort of 101 adult patients with AD recruited from an outpatient clinic. Bacterial swabs were taken at baseline and follow-up from lesional skin, nonlesional skin and the nose. Swabs positive for S. aureus were characterized by spa and the respective clonal complex (CC) type was assigned. Patients were characterized with respect to disease severity [Scoring Atopic Dermatitis (SCORAD)], skin barrier properties [transepidermal water loss (TEWL), pH] and FLG mutations. Results In total, 63 patients participated in a follow-up visit. Twenty-seven patients (43%) were colonized at both visits, 27 were colonized at only one visit and nine (14%) were not colonized at either visit. Of patients colonized at both visits, 52% remained colonized with the same CC type at follow-up. Change in CC type was related to an increase in SCORAD of 10Á7 points; patients who carried the same CC type had a reduction in SCORAD of 4Á4 points. Significantly higher skin pH was found in patients colonized at both visits, while change in CC type was not related to TEWL, pH or FLG mutations. Conclusions The data indicate that temporal variation in S. aureus CC type is linked to flares of the disease.
• Skin barrier impairments in AD associate with S. aureus colonization.
• Staphylococcus aureus is strongly linked to disease severity in AD.
What does this study add?
• Change in S. aureus CC type is related to increased disease severity.
• Staphylococcus aureus CC types undergo temporal variation in less than half of the colonized patients.
Atopic dermatitis (AD) is a common inflammatory skin disease with a complex pathogenesis, involving both skin barrier impairment and immunological dysfunction. Although it is most widely studied in children, the disease affects 2-10% of adults.
1,2 In adulthood it may cause long-lasting and severe symptoms, with a significant negative influence on health-related quality of life. 1, [3] [4] [5] Skin barrier defects are a hallmark in AD and facilitate penetration and entry of microbes, giving patients with AD a predisposition to microbial skin infections. [6] [7] [8] [9] Up to 90% of patients with AD are colonized with Staphylococcus aureus, 10 and despite a strong link between disease severity and S. aureus colonization, [11] [12] [13] [14] the precise role of S.
aureus in the pathogenesis of AD is still unclear. 7, 8 Even though colonization rates are high in AD, temporal variation of S. aureus clonal complex (CC) types in patients with AD has sparsely been investigated and only over short periods of time. 15, 16 Staphylococcus aureus is very clonal, and most patients with AD are colonized with only one CC type. 14 New studies indicate that specific clonal types could be linked to specific host phenotypes, illustrating that host-microbe interactions might be important for colonization of AD skin. 17, 18 As S. aureus is a frequent cause of clinically important infections, and a global increase of resistant strains of S. aureus is reported, patients with AD may serve as a potential risk population due to high rates of S. aureus colonization and frequent use of antibiotic treatment. A better understanding of the role of S. aureus in AD, including temporal variation in clonal types, may help elucidate better strategies for antibiotic use and treatment in this group of patients.
This report is on a clinical follow-up study to explore temporal variations of S. aureus colonization and S. aureus CC type in patients with AD and to relate these variations to disease severity, skin barrier properties and filaggrin gene (FLG) mutations.
Materials and methods

Study design
This was a follow-up study of 101 adult patients with AD. They were recruited from the outpatient clinic of the Department of Dermatology, Bispebjerg Hospital, and through advertising. They had enrolled in a previous study 14 assessing S. aureus colonization, spa types and CC types in the period 2013-15 (baseline values). All patients were invited to participate in a follow-up visit in the 3-month period from November 2016 to January 2017. Inclusion criteria were age > 18 years and presence of AD according to the U.K. criteria 19 when examined at inclusion (baseline). Patients were characterized by demographic data, and FLG mutation status was examined with respect to the common variants in white patients: R501X, 2282del4 and R2447X. 20 Disease severity was assessed by Scoring Atopic Dermatitis (SCORAD). 21 With respect to treatment, patients were included regardless of topical or systemic therapy. All types of treatments were registered.
Skin barrier function
Skin barrier function was assessed by measurements of transepidermal water loss (TEWL) and skin pH (DermaLab; Cortex Technology, Hadsund, Denmark). Measurements were performed in triplicate on the volar forearm on all participants, and mean values were calculated. The participants adjusted to room temperature for 15 min before measurements, and all measurements were performed by the same investigator.
Bacterial swabs and Staphylococcus aureus typing
Three bacterial swabs were taken from each patient (lesional skin, nonlesional skin and nose) using eSwab (Copan, Brescia, Italy). Swabs from lesional skin were taken at the location of eczema, predominantly the arms, and swabs from nonlesional skin were taken predominantly from the elbow crease, or the volar forearms if the patients had eczema in the elbow crease. Swabs were plated onto selective S. aureus plates (chromID S. aureus; bioMerieux, Marcy l'Etoile, France) and incubated overnight at 37°C. DNA was purified from S. aureus isolates using the Qiagen DNeasy Blood and Tissue Purification Kit (Qiagen, Hilden, Germany). The spa typing was performed by polymerase chain reaction and Sanger sequencing of the product.
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The respective clonal complex (CC) types were assigned from the spa type using eBURST (http://eburst.mlst.net). Illumina sequences for the S. aureus isolates are available at the European Nucleotide Archive (http://www.ebi.ac.uk/ena) under the project identification number PRJEB18560.
Ethical considerations
The study was approved by the local ethics committee (project number 1-2014-039) and the Danish Data Protection Agency (project number 01767 BBH-2012-019). All participants received oral and written information, and informed consent was obtained from all participants according to Danish law.
Statistics
The v 2 -test was used for categorical outcomes such as sex, SCORAD group, FLG gene mutation and treatment, to test for differences between patients participating or not participating in the present follow-up study (Table S1 ; see Supporting Information) and patients with or without S. aureus colonization at follow-up (Table 1 ). An independent-samples t-test was used to compare mean age. It was also used to compare colonized vs. not colonized patients and patients with different CC types with regards to SCORAD, TEWL, pH and FLG mutation status. Due to the small sample size, Fisher's exact test was used to detect differences in S. aureus status from baseline to follow-up (Table S2; see Supporting Information). P-values < 0Á05 were considered statistically significant. For statistical analysis, SPSS version 24 was used (IBM, Armonk, NY, U.S.A.).
Results
Of the 101 invited patients with AD, 63 participated in the follow-up study. They included 28 men and 35 women, mean age 35Á8 AE 14Á2 years. Their demographic data and data on disease severity (SCORAD) and treatments are shown in Table 1 .
With respect to the 38 patients not volunteering for the follow-up study, 27 did not respond to e-mail, phone calls or a follow-up letter; nine patients stated that they had no time or interest in participating, and two patients had moved to an unknown address. There was no marked difference between the follow-up cohort and the original cohort regarding sex, age, SCORAD at baseline, FLG mutation status or treatment at baseline (Table S1 ; see Supporting Information).
Staphylococcus aureus colonization
Of the 63 patients included in the follow-up study, 47 were colonized at one or more sample sites with S. aureus at baseline. Of these, 27 (57%) were still colonized at follow-up, and the remaining patients had no S. aureus at follow-up (Fig. 1) . At baseline, 16 patients were not colonized, of whom seven (44%) were colonized at follow-up. In total, 34 patients (54%) were colonized with S. aureus in one or more sample sites at follow-up (Fig. 1) . The prevalences of S. aureus colonization of lesional skin, nonlesional skin and nose in these patients were 33%, 10% and 41%, respectively.
Included participants had either 1Á5 or 4 years of follow-up time, as the first study included patients over two time periods. 14 Comparing colonization rates of patients with a 1Á5-year follow-up (n = 37) vs. 4-year follow-up (n = 26) showed no marked differences (Table S2; see Supporting Information) , with 57% and 50% of patients colonized at follow-up, respectively.
Staphylococcus aureus spa types and CC types
Twenty-six different spa types and nine different CC types were detected among the 34 patients with AD positive for S. aureus colonization in the follow-up study. Thirty-two patients (94%) carried only one spa type and one CC type in all three sampling sites, while two patients carried S. aureus isolates with different spa and CC types. The most frequent spa types were t008, t091, t127 and t254, and the most frequent CC types were CC1, CC8 and CC15 (Table 2) .
Temporal variation
Temporal changes in the S. aureus CC type of all 47 patients colonized at baseline were analysed. This showed that 14 (30%) had the same CC type, 11 (23%) had a different CC type, two patients were inconsistent (4%) (changed CC type in one sample site but carried the same CC type in another sample site) and 20 (43%) were not colonized. Thus, in 52% (14 of 27) of the colonized patients, the CC type remained the same at follow-up as it was at baseline (Table 3) . There was no difference in change of CC type between patients with 1Á5 years and 4 years of follow-up (data not shown).
Disease severity
The mean SCORAD for patients colonized with S. aureus in at least one of the three sample sites (n = 34) at follow-up was 36Á6 AE 18Á8, and the mean SCORAD for patients not colonized with S. aureus (n = 28) was 28Á4 AE 16Á0 (P = 0Á067). Patients who were not colonized at baseline or at follow-up had lower SCORAD (25Á0) than patients colonized at both visits (38Á8) (P = 0Á051) ( Table 4 ). In relation to temporal variation, the mean SCORAD was 30Á3 in patients who carried the same CC type (n = 14), compared with 47Á4 in patients who changed to a different CC type (n = 11) (P = 0Á03). Patients who changed CC type had an increase in mean SCORAD from 36Á8 at baseline to 47Á4 at follow-up, whereas patients who carried the same CC type had a reduction in mean SCORAD from 34Á7 at baseline to 30Á3 at follow-up (P = 0Á08) (Fig. 2) .
Skin barrier
The mean TEWL measured at follow-up in patients colonized at both baseline and follow-up was not significantly different (13Á3 g m À2 h À1 ) from that in patients who were not colonized at either visit (11Á5 g m À2 h À1 ) (P = 0Á39) ( Table 4 ).
The mean skin pH in patients colonized with S. aureus at both baseline and follow-up was higher (5Á9) than in those not colonized at either visit (5Á5) (P = 0Á015). In relation to temporal variation, there was no relation between TEWL, pH or presence of FLG mutations and change of CC type (Table 5 ).
Discussion
Our main finding in the present study is that 57% of patients (27 of 47) with AD colonized with S. aureus at baseline were also colonized at follow-up after 1Á5-4 years. Of these, 14 (52%) carried the same CC type, 11 (41%) had a different CC type and two patients (7%) were inconsistent, having changed CC type in one location but kept the same CC type in another. Change in CC type was related to a higher score of disease severity, which was not seen for those who were colonized with the same CC type at both sample time points. Although colonization with S. aureus is generally accepted to be associated with increased severity and flares of AD, only a few studies have examined the temporal variation of colonization and spa and CC types 15, 16 and related this to disease severity. Our findings that only 57% of patients initially colonized with S. aureus were colonized when re-examined after 1Á5-4 years, and that 43% were colonized at only one visit, illustrate that colonization changes over time. This probably also reflects the relapsing course of this disease, as colonization likely occurs in relation to worsening of the eczema. With respect to spa and CC types, most patients (94%) carried only one spa and CC type at the three sampling sites. This indicates that intrapersonal spread from one localization to another within the individual is of major importance, and that skin and nasal colonization is linked, as previously reported. 23 We recently showed a host-microbe interaction with respect Patients who carried the same Staphylococcus aureus CC type at the baseline visit and follow-up visit had a reduction in SCORAD from 34Á7 to 30Á3, whereas patients who changed CC type from baseline to follow-up had an increase in SCORAD from 36Á8 to 47Á4 (P = 0Á08). 
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Values are n (%). Three patients were colonized with two different CC types. Two patients changed CC type in one location but kept the same CC type in another location. Therefore, these patients are counted twice in the table. (27) 19 (51) Values are n (%).
to CC types of S. aureus, with CC1 as the dominant clone in patients with AD, 14 and also in respect to filaggrin mutations, 17 suggesting that certain clones are favoured by a certain environment. In the follow-up study, CC1 remained the dominant clone in patients with AD, as reported at baseline; however, CC15 was equally prevalent. Considering the theory that specific S. aureus clones are related to specific environments it could be expected that the same bacterial clone would be recognized years later, when examining patients with a chronic skin disease. However, lesional skin varies over time in AD, and samples from lesional skin had therefore changed for many patients at the follow-up visit. Despite this, our data revealed a constant CC type in 52% of the colonized patients. Preservation of the same CC type may be related to the specific host environment of the bacteria. However, it may also be explained by constantly repeated recolonization of patients with AD by household dust in their homes or by creams used for treatment, both of which have been shown to contain large amounts of S. aureus. 24 Whether different treatments could affect the temporal variation in CC type would be interesting to explore, although it would require much larger populations.
Our finding that change in CC type is related to an increase in disease severity supports a recent study in children with AD. 16 This finding suggests that different CC types might harbour different virulence factors, and that the patient's immune system needs to adjust to this. Even though we report a change in CC type in relation to disease severity, other factors should be taken into consideration as they are known to influence AD severity, including change in treatment regimens, climate and other disease. We found no relation between change in CC type and skin barrier properties including FLG mutations; however, our population was too small to make any statistical conclusions on this. Skin pH differed between patients colonized at both visits and patients not colonized at either visit, being significantly higher in the colonized population. Low skin pH might be a protective factor against S. aureus colonization, as acidic pH has been shown to impact S. aureus skin adhesion. 25 Furthermore, barrier enzymes, like proteases, are affected by skin pH, [26] [27] [28] and hence increased skin pH could cause barrier disruption and a more vulnerable skin barrier, thereby facilitating microbial entry. Another explanation for this finding is that S. aureus colonization disturbs the balance of the skin microbiome, causing alterations in the skin barrier and protective mechanisms like AMP expression together with inflammation, causing pH to rise. It could also be that the bacteria themselves secrete alkaline substances.
Strengths of the present study are that this is a follow-up study, which is rare, with presentation of clinical data for a common challenge in the management of AD. The study includes a long follow-up period with detailed characterization of patients and bacterial colonization. The study is limited by the relatively low number of participants; however, publications on the temporal changes of S. aureus colonization with respect to CC type in adult patients with AD are scarce and, therefore these data are very useful for future studies.
Staphylococcus aureus colonization is a major challenge in the management of AD. It affects up to 90% of patients, making this group of patients a potential risk for harbouring resistant bacteria. Worldwide reports of an increase in resistant bacteria, including methicillin-resistant S. aureus, point towards the need for new ways of managing bacterial infections, and more knowledge of the colonization patterns might help us to develop new strategies to combat infections.
In conclusion, we report that change in S. aureus CC type in adult patients with AD is related to higher disease severity score. The fact that half of the patients remain colonized over time with the same CC type points towards a constant colonization in a large group of these patients. 
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